» Articles » PMID: 28674080

Macrophage Deficiency of MiR-21 Promotes Apoptosis, Plaque Necrosis, and Vascular Inflammation During Atherogenesis

Overview
Journal EMBO Mol Med
Specialty Molecular Biology
Date 2017 Jul 5
PMID 28674080
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis, the major cause of cardiovascular disease, is a chronic inflammatory disease characterized by the accumulation of lipids and inflammatory cells in the artery wall. Aberrant expression of microRNAs has been implicated in the pathophysiological processes underlying the progression of atherosclerosis. Here, we define the contribution of miR-21 in hematopoietic cells during atherogenesis. Interestingly, we found that miR-21 is the most abundant miRNA in macrophages and its absence results in accelerated atherosclerosis, plaque necrosis, and vascular inflammation. miR-21 expression influences foam cell formation, sensitivity to ER-stress-induced apoptosis, and phagocytic clearance capacity. Mechanistically, we discovered that the absence of miR-21 in macrophages increases the expression of the miR-21 target gene, MKK3, promoting the induction of p38-CHOP and JNK signaling. Both pathways enhance macrophage apoptosis and promote the post-translational degradation of ABCG1, a transporter that regulates cholesterol efflux in macrophages. Altogether, these findings reveal a major role for hematopoietic miR-21 in atherogenesis.

Citing Articles

The synergistic role of gut microbiota and RNA in metabolic diseases: mechanisms and therapeutic insights.

Huang Z, Yao Q, Ma S, Zhou J, Wang X, Meng Q Front Microbiol. 2025; 16:1504395.

PMID: 39944642 PMC: 11814227. DOI: 10.3389/fmicb.2025.1504395.


Could hypoxic conditioning augment the potential of mesenchymal stromal cell-derived extracellular vesicles as a treatment for type 1 diabetes?.

Forkan C, Shrestha A, Yu A, Chuang C, Pociot F, Yarani R Stem Cell Res Ther. 2025; 16(1):37.

PMID: 39901225 PMC: 11792614. DOI: 10.1186/s13287-025-04153-4.


A Thorough Navigation of miRNA's Blueprint in Crafting Cardiovascular Fate.

Nazir A, Uwishema O, Shariff S, Franco W, El Masri N, Ayele N Health Sci Rep. 2024; 7(11):e70136.

PMID: 39502130 PMC: 11535861. DOI: 10.1002/hsr2.70136.


Targeted delivery of anti-miRNA21 sensitizes PD-L1 tumor to immunotherapy by promoting immunogenic cell death.

Kim E, Choi J, Jang H, Kim Y, Lee J, Ryu Y Theranostics. 2024; 14(10):3777-3792.

PMID: 38994018 PMC: 11234275. DOI: 10.7150/thno.97755.


Investigating the potential neuroprotective benefits of taurine and Dihydrotestosterone and Hydroxyprogesterone levels in SH-SY5Y cells.

Almohaimeed H, Almars A, Alsulaimani F, Basri A, Althobaiti N, Albalaw A Front Aging Neurosci. 2024; 16:1379431.

PMID: 38867846 PMC: 11168113. DOI: 10.3389/fnagi.2024.1379431.


References
1.
Sheedy F, Palsson-McDermott E, Hennessy E, Martin C, OLeary J, Ruan Q . Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol. 2009; 11(2):141-7. DOI: 10.1038/ni.1828. View

2.
Suarez Y, Wang C, Manes T, Pober J . Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J Immunol. 2009; 184(1):21-5. PMC: 2797568. DOI: 10.4049/jimmunol.0902369. View

3.
Teruel-Montoya R, Kong X, Abraham S, Ma L, Kunapuli S, Holinstat M . MicroRNA expression differences in human hematopoietic cell lineages enable regulated transgene expression. PLoS One. 2014; 9(7):e102259. PMC: 4100820. DOI: 10.1371/journal.pone.0102259. View

4.
Galkina E, Ley K . Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol. 2009; 27:165-97. PMC: 2734407. DOI: 10.1146/annurev.immunol.021908.132620. View

5.
Chamorro-Jorganes A, Lee M, Araldi E, Landskroner-Eiger S, Fernandez-Fuertes M, Sahraei M . VEGF-Induced Expression of miR-17-92 Cluster in Endothelial Cells Is Mediated by ERK/ELK1 Activation and Regulates Angiogenesis. Circ Res. 2015; 118(1):38-47. PMC: 4703066. DOI: 10.1161/CIRCRESAHA.115.307408. View